$KALV
KalVista Pharmaceuticals, Inc. Stock $kalv

$kalv Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000156459019034364 Filed on September 09, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q3
Revenue	$3.369M	$2.926M	$3.718M
YoY Change	-9.39%	-39.55%	3772.92%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.250M	$3.050M	$2.370M
YoY Change	37.13%	55.61%	14.49%
% of Gross Profit
Research & Development	$9.690M	$11.14M	$8.360M
YoY Change	15.91%	90.43%	140.51%
% of Gross Profit
Depreciation & Amortization	$121.0K	$120.0K	$50.00K
YoY Change	142.0%	140.0%	56.25%
% of Gross Profit
Operating Expenses	$12.93M	$14.19M	$10.73M
YoY Change	20.56%	81.66%	93.31%
Operating Profit	-$9.564M		-$7.009M
YoY Change	36.45%		28.53%
Interest Expense	$140.0K	$350.0K	$160.0K
YoY Change	-12.5%	6.06%	-633.33%
% of Operating Profit
Other Income/Expense, Net	$2.090M	$2.510M	$1.979M
YoY Change	5.61%	26.13%	276.95%
Pretax Income	-$7.340M	-$8.400M	-$5.030M
YoY Change	45.92%	1172.73%	2.03%
Income Tax		$120.0K
% Of Pretax Income
Net Earnings	-$7.338M	-$8.526M	-$5.030M
YoY Change	45.88%	1197.72%	2.07%
Net Earnings / Revenue	-217.81%	-291.39%	-135.29%
Basic Earnings Per Share
Diluted Earnings Per Share	-$419.7K	-$496.5K	-$465.7K
COMMON SHARES
Basic Shares Outstanding	17.82M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.4M	$100.8M	$48.10M
YoY Change	108.66%	97.28%	81.51%
Cash & Equivalents	$30.11M	$32.01M	$48.07M
Short-Term Investments	$70.26M	$68.81M
Other Short-Term Assets	$2.700M	$3.400M	$1.500M
YoY Change	80.0%	126.67%	87.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$115.7M	$115.5M	$55.20M
YoY Change	109.64%	94.59%	82.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.255M	$2.413M	$2.300M
YoY Change	-1.96%	31.43%	283.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$173.0K	$173.0K	$173.0K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$4.165M	$2.586M	$2.400M
YoY Change	73.54%	28.72%	300.0%
TOTAL ASSETS
Total Short-Term Assets	$115.7M	$115.5M	$55.20M
Total Long-Term Assets	$4.165M	$2.586M	$2.400M
Total Assets	$119.9M	$118.1M	$57.60M
YoY Change	108.13%	92.43%	87.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.103M	$2.860M	$2.300M
YoY Change	34.91%	99.58%	21.05%
Accrued Expenses	$4.261M	$5.647M	$3.100M
YoY Change	37.45%	82.93%	82.35%
Deferred Revenue	$6.023M	$9.545M	$17.21M
YoY Change	-65.0%	-48.34%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$100.0K	$200.0K
YoY Change		-50.0%	0.0%
Total Short-Term Liabilities	$13.97M	$18.05M	$22.90M
YoY Change	-39.01%	-22.24%	502.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$4.100M	$3.300M	$8.500M
YoY Change	-51.76%	-69.72%
Total Long-Term Liabilities	$4.050M	$3.342M	$8.465M
YoY Change	-52.16%	-69.4%	3874.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.97M	$18.05M	$22.90M
Total Long-Term Liabilities	$4.050M	$3.342M	$8.465M
Total Liabilities	$18.02M	$21.39M	$31.40M
YoY Change	-42.62%	-37.33%	665.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.81M	-$92.48M
YoY Change		29.05%
Common Stock	$203.7M	$191.1M
YoY Change		91.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$101.9M	$96.74M	$26.25M
YoY Change
Total Liabilities & Shareholders Equity	$119.9M	$118.1M	$57.60M
YoY Change	108.13%	92.43%	87.11%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q3
OPERATING ACTIVITIES
Net Income	-$7.338M	-$8.526M	-$5.030M
YoY Change	45.88%	1197.72%	2.07%
Depreciation, Depletion And Amortization	$121.0K	$120.0K	$50.00K
YoY Change	142.0%	140.0%	56.25%
Cash From Operating Activities	-$11.28M	-$10.52M	-$6.212M
YoY Change	81.5%	76.81%	39.66%
INVESTING ACTIVITIES
Capital Expenditures	$98.00K	-$270.0K	$565.0K
YoY Change	-82.65%	-75.23%	413.64%
Acquisitions
YoY Change
Other Investing Activities	-$1.430M	-$13.77M
YoY Change
Cash From Investing Activities	-$1.530M	-$14.04M	-$565.0K
YoY Change	170.8%	1188.07%	413.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$11.42M		$5.000M
YoY Change	128.44%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.40M	150.0K	4.948M
YoY Change	130.4%	-1600.0%
NET CHANGE
Cash From Operating Activities	-11.28M	-10.52M	-6.212M
Cash From Investing Activities	-1.530M	-14.04M	-565.0K
Cash From Financing Activities	11.40M	150.0K	4.948M
Net Change In Cash	-1.899M	-24.41M	-1.829M
YoY Change	3.83%	246.24%	-59.87%
FREE CASH FLOW
Cash From Operating Activities	-$11.28M	-$10.52M	-$6.212M
Capital Expenditures	$98.00K	-$270.0K	$565.0K
Free Cash Flow	-$11.37M	-$10.25M	-$6.777M
YoY Change	67.82%	110.91%	48.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2371000
CY2019Q3	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18052000
CY2019Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1737000
CY2019Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2019Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	55 Cambridge Parkway
CY2019Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17815493
CY2019Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 901E
CY2019Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Cambridge
CY2019Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2019Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02142
CY2019Q3	dei	City Area Code CityAreaCode	857
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2255000
CY2019Q3	dei	Local Phone Number LocalPhoneNumber	999-0075
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32006000
CY2019Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	68805000
CY2019Q2	kalv	Research And Development Tax Credits Receivable ResearchAndDevelopmentTaxCreditsReceivable	11315000
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3420000
CY2019Q2	us-gaap	Assets Current AssetsCurrent	115546000
CY2019Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2873000
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9545000
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2413000
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6023000
CY2019Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0915291
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	580000
CY2019Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2019Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3247000
CY2019Q3	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3342000
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1926000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	12933000
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	10727000
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7009000
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	590000
CY2019Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-453000
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	67000
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1979000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-89000
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	28000
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1320000
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11422000
CY2019Q3	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	32000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1074000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	27253000
CY2018Q3	kalv	Adjustments To Additional Paid In Capital Increase In Equity Due To Common Stock Subscription Agreement AdjustmentsToAdditionalPaidInCapitalIncreaseInEquityDueToCommonStockSubscriptionAgreement	5000000
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-7338000
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-5030000
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	121000
CY2018Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	50000
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1074000
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	347000
CY2019Q3	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	29000
CY2019Q3	kalv	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	138000
CY2019Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	35000
CY2019Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-454000
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-6000
CY2019Q3	kalv	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	2060000
CY2018Q3	kalv	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	-919000
CY2019Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-561000
CY2018Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	69000
CY2019Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	392000
CY2018Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1126000
CY2019Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1117000
CY2018Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	157000
CY2019Q3	kalv	Increase Decrease In Lease Obligations IncreaseDecreaseInLeaseObligations	-137000
CY2019Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3369000
CY2018Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3718000
CY2019Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11275000
CY2018Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6212000
CY2019Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	98000
CY2018Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	565000
CY2019Q3	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	19646000
CY2019Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	18214000
CY2019Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1530000
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	173000
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2019Q3	dei	Entity File Number EntityFileNumber	001-36830
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3342000
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q3	us-gaap	Assets Assets	119884000
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2860000
CY2019Q2	us-gaap	Assets Assets	118132000
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3103000
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5647000
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4261000
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30107000
CY2019Q3	kalv	Research And Development Tax Credits Receivable ResearchAndDevelopmentTaxCreditsReceivable	12625000
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	70259000
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2728000
CY2019Q3	us-gaap	Assets Current AssetsCurrent	115719000
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	173000
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13967000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9564000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-61000
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1177000
CY2019Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4050000
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	203650000
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	191123000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	101867000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	96738000
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119884000
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118132000
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3718000
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	18000
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99814000
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92476000
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1987000
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17815493
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17277750
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17815493
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17277750
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3369000
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	17000
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	347000
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	26250000
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	89000
CY2018Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-565000
CY2019Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	54000
CY2018Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	52000
CY2019Q3	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	32000
CY2019Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11422000
CY2018Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000
CY2019Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11400000
CY2018Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4948000
CY2019Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-494000
CY2018Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1156000
CY2019Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1899000
CY2018Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2985000
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51055000
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48070000
CY2019Q3	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	47000
CY2018Q3	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	100000
CY2019Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	123000
CY2019Q3	kalv	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	100400000
CY2019Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	973000
CY2019Q3	kalv	Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure	71232000
CY2019Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	69783000
CY2019Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	499000
CY2019Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	23000
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	70259000
CY2019Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	68365000
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	441000
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000
CY2019Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	68805000
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	39209000
CY2019Q3	kalv	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	18055000
CY2019Q3	kalv	Available For Sale Securities Debt Maturities After Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsFairValue	12995000
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	775000
CY2019Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1949000
CY2019Q3	kalv	Accrued Research Expense Current AccruedResearchExpenseCurrent	3054000
CY2019Q2	kalv	Accrued Research Expense Current AccruedResearchExpenseCurrent	3065000
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	171000
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	186000
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	447000
CY2019Q3	kalv	Contractual Obligation Remaining Commitment Including Cancellation Provisions ContractualObligationRemainingCommitmentIncludingCancellationProvisions	6400000
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	177000
CY2019Q3	kalv	Finance Lease Costs FinanceLeaseCosts	54000
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	9000
CY2019Q3	us-gaap	Lease Cost LeaseCost	240000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	528000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	616000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	324000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	188000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	92000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	374000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2122000
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	365000
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1757000
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	175000
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	54000
CY2019Q2	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	54000
CY2019Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	54000
CY2019Q2	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	54000
CY2019Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	54000
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	687000
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	474000
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	328000
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	194000
CY2019Q2	kalv	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	495000
CY2019Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2178000

Files In Submission

Name	View Source	Status
0001564590-19-034364-index-headers.html	Edgar Link	pending
0001564590-19-034364-index.html	Edgar Link	pending
0001564590-19-034364.txt	Edgar Link	pending
0001564590-19-034364-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kalv-10q_20190731.htm	Edgar Link	pending
kalv-20190731.xml	Edgar Link	completed
kalv-20190731.xsd	Edgar Link	pending
kalv-20190731_cal.xml	Edgar Link	unprocessable
kalv-20190731_def.xml	Edgar Link	unprocessable
kalv-20190731_lab.xml	Edgar Link	unprocessable
kalv-20190731_pre.xml	Edgar Link	unprocessable
kalv-ex311_6.htm	Edgar Link	pending
kalv-ex312_10.htm	Edgar Link	pending
kalv-ex321_8.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KALV
KalVista Pharmaceuticals, Inc. Stock $kalv

2019 Q3 Form 10-Q Financial Statement

#000156459019034364 Filed on September 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KALV KalVista Pharmaceuticals, Inc. Stock $kalv

2019 Q3 Form 10-Q Financial Statement

#000156459019034364 Filed on September 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KALV
KalVista Pharmaceuticals, Inc. Stock $kalv